Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients

PURPOSE: Most patients suffering from advanced lung cancer die within a few months. To exploit new therapy regimens we need better methods for the assessment of a therapy response. MATERIAL AND METHODS: In a pilot study we prospectively enrolled 36 patients with advanced NSCLC and SCLC (34 stage IV,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Bernd, Beyer, Julia, Dietrich, Dimo, Bork, Ines, Liebenberg, Volker, Fleischhacker, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326280/
https://www.ncbi.nlm.nih.gov/pubmed/25675432
http://dx.doi.org/10.1371/journal.pone.0118195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326280/
https://www.ncbi.nlm.nih.gov/pubmed/25675432
http://dx.doi.org/10.1371/journal.pone.0118195

Ejemplares similares